Zhejiang Jingxin Pharmaceutical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jin Zhiping
Chief executive officer
CN¥1.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 11.2yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt
Oct 04
Zhejiang Jingxin Pharmaceutical Co., Ltd.'s (SZSE:002020) Low P/E No Reason For Excitement
Sep 12Zhejiang Jingxin Pharmaceutical (SZSE:002020) Has Announced A Dividend Of CN¥0.30
May 21Zhejiang Jingxin Pharmaceutical's (SZSE:002020) Problems Go Beyond Weak Profit
Apr 08We Think Zhejiang Jingxin Pharmaceutical (SZSE:002020) Can Stay On Top Of Its Debt
Mar 29CEO
Jin Zhiping (43 yo)
11.2yrs
Tenure
CN¥1,231,400
Compensation
Mr. Jin Zhiping has been Non-Independent Director of Zhejiang Jingxin Pharmaceutical Co., Ltd. since October 8, 2013 and serves as its President.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 11.2yrs | CN¥1.23m | no data | |
| VP, CFO & Director | 11.2yrs | CN¥957.20k | 0.044% CN¥ 4.9m | |
| Secretary of the Board & Non-Independent Director | 5.2yrs | CN¥940.20k | no data | |
| Chairman of the Board | 11.2yrs | CN¥1.64m | 20.77% CN¥ 2.3b | |
| Vice Chairman | 11.2yrs | CN¥1.17m | 0.42% CN¥ 46.1m | |
| Chairman of the Supervisory Board | no data | CN¥310.80k | no data | |
| Employee Representative Member of the Supervisory Board | no data | no data | no data | |
| Independent Director | 2.2yrs | CN¥80.00k | no data | |
| Supervisor | 5.2yrs | no data | no data | |
| Non-Independent Director | 2.2yrs | CN¥683.40k | no data | |
| Independent Director | 2.2yrs | CN¥80.00k | no data | |
| Independent Director | 2.2yrs | CN¥80.00k | no data |
5.2yrs
Average Tenure
51yo
Average Age
Experienced Board: 002020's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 04:20 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Jingxin Pharmaceutical Co., Ltd. is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Chen | Chasing Securities |
| Shanshan Li | China Merchants Securities Co. Ltd. |
| Shitong Han | Citic Securities Co., Ltd. |